Department of Surgery, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Pediatr Blood Cancer. 2024 Nov;71(11):e31269. doi: 10.1002/pbc.31269. Epub 2024 Aug 13.
Documentation of intraoperative oncologic findings varies greatly across narrative operative reports (NRs). An international panel of childhood cancer experts recently developed a synoptic operative report (SR) for childhood cancer surgeries. The aim of this study was to compare the documentation of critical intraoperative findings in NRs versus SRs.
A single-center retrospective review of all surgical resections of primary solid tumors at our pediatric oncology center was conducted from June 2023 to March 2024, after an institutional SR was piloted from October 2023 onwards. Data collected included the presence or absence of six components included in standard pediatric oncology NRs. Inclusion rates were calculated as percentages for each component. Due to the small sample, the Fisher's exact test was used for all hypothesis testing.
Seventy primary tumor resections were performed during the study period, as documented by 38 NRs and 32 SRs. All operative reports after October 2023 were SRs. Completeness of tumor resection and specimen naming were consistently documented in NRs (86% and 100%, respectively) and SRs (100% and 100%, respectively). The presence/absence of three components-intraoperative tumor spillage (31%), vascular involvement (31%), and lymph node sampling (26%)-were documented in fewer than a third of the NRs. Documentation of the presence/absence of locoregional spread, intraoperative tumor spillage, vascular involvement, and lymph node sampling was significantly better in SRs than in NRs.
Adoption of SRs significantly improved the documentation of critical intraoperative findings. Thus, we recommend using SRs in pediatric solid tumor surgery.
术中肿瘤学发现的记录在叙事手术报告(NR)中差异很大。一个国际儿童癌症专家小组最近为儿童癌症手术制定了综合手术报告(SR)。本研究的目的是比较 NR 和 SR 中关键术中发现的记录。
对 2023 年 6 月至 2024 年 3 月期间我院儿童肿瘤中心所有原发性实体瘤手术切除进行单中心回顾性研究,在 2023 年 10 月开始试行机构性 SR 后。收集的数据包括标准儿童肿瘤 NR 中包含的六个组件的存在或缺失。每个组件的纳入率均以百分比计算。由于样本量小,因此所有假设检验均使用 Fisher 精确检验。
在研究期间进行了 70 例原发性肿瘤切除术,由 38 份 NR 和 32 份 SR 记录。2023 年 10 月之后的所有手术报告均为 SR。肿瘤切除的完整性和标本命名在 NR(分别为 86%和 100%)和 SR(分别为 100%和 100%)中均得到一致记录。术中肿瘤溢漏(31%)、血管受累(31%)和淋巴结取样(26%)的存在/缺失在不到三分之一的 NR 中记录。SR 中记录的局部区域扩散、术中肿瘤溢漏、血管受累和淋巴结取样的存在/缺失明显优于 NR。
采用 SR 显著改善了关键术中发现的记录。因此,我们建议在儿童实体瘤手术中使用 SR。